Healthcare


 AstraZeneca vs GlaxoSmithKline: Pharma stocks to keep an eye on

AstraZeneca vs GlaxoSmithKline: Pharma stocks to keep an eye on

April 20, 2022 08:42 AM BST| By Rishika Raina

Leading British pharmaceutical company GlaxoSmithKline plc (LON: GSK) has been in the limelight lately after securing triumph for its drug with US regulator Food and Drug Administration (FDA) in relation to the treatment of anaemia in patients suff.....

 Is OKYO Pharma (LON: OKYO) going for a Nasdaq listing?

Is OKYO Pharma (LON: OKYO) going for a Nasdaq listing?

March 08, 2022 12:42 PM GMT| By Rishika Raina

Highlights OKYO Pharma is aiming to get its ADSs listed on Nasdaq and has submitted a registration statement with the US SEC for the same. The exclusive book-running manager for the IPO is the California-based investment banking firm ThinkEquit.....

 GlaxoSmithKline (LON: GSK) to start a new business era with Haleon

GlaxoSmithKline (LON: GSK) to start a new business era with Haleon

February 23, 2022 09:28 AM GMT| By Sreenivas D Ajankar

Highlights GlaxoSmithKline Plc has come one step closer to the proposed demerger of its consumer healthcare business by announcing the name of the new entity. The proposed demerger will be a milestone in the company’s history which was fi.....

 AstraZeneca (AZN) predicts higher sales in 2022: Should you buy now?

AstraZeneca (AZN) predicts higher sales in 2022: Should you buy now?

February 11, 2022 06:43 AM GMT| By Rishika Raina

Highlights  London’s FTSE100 index was in a buoyant mood on 10 February after it saw third day of gains in a row. The total revenues of AstraZeneca increased by 41% to $37,417 million in 2021, and it has raised its 2022 sales forecas.....

 GlaxoSmithKline (GSK) shares: Are they worth your attention?

GlaxoSmithKline (GSK) shares: Are they worth your attention?

February 10, 2022 10:21 AM GMT| By Priya Bhandari

British pharmaceutical giant GlaxoSmithKline Plc (LON: GSK) is back in the news after the company reported robust results for the year 2021 before the structured disposal of its consumer healthcare division. The company reported a 9% hike in its ad.....

 GlaxoSmithKline (GSK) settles case with Gilead: Should you buy now?

GlaxoSmithKline (GSK) settles case with Gilead: Should you buy now?

February 02, 2022 01:52 PM GMT| By Sreenivas D Ajankar

The UK-based pharmaceutical company, GlaxoSmithKline Plc (LON: GSK), which is into research and development of medicine and consumer healthcare products, announced that one of its investment companies, ViiV Healthcare, which is jointly owned with P.....

 Pod Point (PODP) & BP: 2 FTSE stocks to supercharge your portfolio

Pod Point (PODP) & BP: 2 FTSE stocks to supercharge your portfolio

February 02, 2022 01:13 PM GMT| By Sreenivas D Ajankar

Highlights  FairCharge, a national EV-related campaign, called on the UK treasury to stop the unfair VAT policy levied on EVs when they are charged from public charging points. Public charging VAT currently stands at 20 per cent, while dom.....

 Sareum (SAR) & Hemogenyx (HEMO): 2 LSE pharma stocks to buy today

Sareum (SAR) & Hemogenyx (HEMO): 2 LSE pharma stocks to buy today

January 17, 2022 02:34 PM GMT| By Suhita Poddar

Pharma and biotech-focused companies have seen huge investments after the onset of the pandemic. The UK received record levels of investment into its life sciences sector in 2021, with VC (Venture Capital) and PE (Private Equity) investment into th.....

 GSK and Unilever’s offer:  What shareholders can gain?

GSK and Unilever’s offer:  What shareholders can gain?

January 17, 2022 11:23 AM GMT| By Sreenivas D Ajankar

Highlights The consumer health business of GSK received multiple takeover bids, including a £50 billion bid just before Christmas in 2021 by consumer-goods giant, Unilever Plc. Unilever Plc’s cash and shares offer was rejected as it.....

 AstraZeneca working on a new vaccine for Omicron:3 stocks to eye on

AstraZeneca working on a new vaccine for Omicron:3 stocks to eye on

December 22, 2021 09:17 AM GMT| By Sreenivas D Ajankar

Highlights  FTSE 100 listed global pharmaceutical company AstraZeneca Pls said that it is working on developing a new vaccine for the Omicron variant. Many vaccine makers like Pfizer and Moderna are working on new vaccines and hope to star.....

 Top 5 healthcare stocks of 2021

Top 5 healthcare stocks of 2021

December 13, 2021 02:32 PM GMT| By Rishika Raina

Highlights  Healthcare sector has shown tremendous growth amid the Covid-19 pandemic. The healthcare sector includes a range of companies providing drugs, medical devices, and healthcare providers. Investing in the stocks of these healthc.....

 GSK’s covid drug gets MHRA nod; maybe 'effective' against Omincron

GSK’s covid drug gets MHRA nod; maybe 'effective' against Omincron

December 02, 2021 10:03 AM GMT| By Sreenivas D Ajankar

Highlights  The UK-based GlaxoSmithKline has received initial approval from the UK regulator for its sotrovimab, a monoclonal antibody, which could be effective against Omicron variant. The UK pharmaceutical industry received a significant.....

 Omicron scare: WHO issues warning, healthcare stocks to invest in

Omicron scare: WHO issues warning, healthcare stocks to invest in

November 30, 2021 11:54 AM GMT| By Team Kalkine Media

Highlights  Initially detected in South Africa, the new Covid variant Omricon has created panic worldwide due to higher risk of re-infections. Boosting the vaccine accessibility for poor countries has again been called for by WHO. To prev.....

 Omega Diagnostics (ODX) shares slump over 30%: Should you hold?

Omega Diagnostics (ODX) shares slump over 30%: Should you hold?

November 25, 2021 02:04 PM GMT| By Nidhi Gupta

Highlights  Omega Diagnostics Group reported a statutory loss of £2.75 million for the H1 2021, as its contract with the UK Department of Health and Social Care (DHSC) ended. Omega Diagnostics’ revenue from its Global Heal.....

 Nuformix (NFX) & MyHealthChecked (MHC): 2 pharma penny stocks to buy

Nuformix (NFX) & MyHealthChecked (MHC): 2 pharma penny stocks to buy

November 25, 2021 11:00 AM GMT| By Nidhi Gupta

Highlights Nuformix published positive pre-clinical data on its new inhaled treatment NXP002 for idiopathic pulmonary fibrosis. MyHealthChecked has announced the launch of two new COVID-19 home testing services for travellers in the UK. Pe.....

 AstraZeneca (AZN) shares: A long term buy from pharma space

AstraZeneca (AZN) shares: A long term buy from pharma space

November 24, 2021 11:49 AM GMT| By Suhita Poddar

Highlights AstraZeneca opened new research and development called Discovery Centre (DISC) is worth about £1 billion, in Cambridge It is the biggest science lab in the UK, tied with Francis Crick Institute located in London Pharmaceut.....

 2 pharma penny stocks returning 200% in a year: Buy call?

2 pharma penny stocks returning 200% in a year: Buy call?

November 17, 2021 10:44 AM GMT| By Nidhi Gupta

Pharmaceutical firms often serve as attractive investment options for investors. These stocks belong to healthcare firms focused on research and development, production as well as distribution of pharmaceutical products. The booming healthcare indu.....

 AstraZeneca (AZN) or Nuformix (NFX): Which pharma stock to buy?

AstraZeneca (AZN) or Nuformix (NFX): Which pharma stock to buy?

November 12, 2021 11:53 AM GMT| By Suhita Poddar

The UK pharma and biotechnology sector has laid out certain recommendations to increase the attractiveness of the sector, according to a new report by industry body the Association of the British Pharmaceutical Industry (ABPI). Drug manufacturers .....

 Should you buy these 2 pharma penny stocks now?

Should you buy these 2 pharma penny stocks now?

November 08, 2021 01:36 PM GMT| By Suhita Poddar

The biotech and life sciences sector in the UK has seen a record level of investment in the first 3 quarters of 2021, raising up to £3 billion, according to industry body BioIndsutry Association and data firm Clarivate. The first 3 quarters .....

 Sunak increases healthcare spending by £44 bn: 2 stocks to buy

Sunak increases healthcare spending by £44 bn: 2 stocks to buy

October 27, 2021 03:01 PM BST| By Suhita Poddar

The UK’s chancellor of exchequer, Rishi Sunak, boosted the UK’s resource expenditure on the healthcare sector in the Autumn Budget announced today. As per the latest spending review, the resource spending in the healthcare sector will .....

Recent Articles






Investing Tips

Previous Next